Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PCAS M&A Activity 2013

Mar 20, 2013

1590_iss_2013-03-20_f8588864-ae60-4231-8b77-d7ec5e4f137b.pdf

M&A Activity

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

Longjumeau, March 20, 2013

Sale of Société Béarnaise de Synthèse (SBS) to DRT

Following the press release of February 20, 2013 concerning 2012 Results, PCAS finalized today the sale of Société Béarnaise de Synthèse (SBS), specialized in the production of acrolein-based synthesis intermediates, to the French industrial Group DRT, specialized in the development of rosin and turpentine extracted from pine resin. This sale was completed in accordance with the conditions outlined in the above-mentioned press release.

Next date: 2013 shareholder's meeting on April 24, 2013, 9.00 a.m. in Longjumeau

About PCAS:

Founded in 1962, PCAS is an international fine and specialty chemicals group that shares an ambition for excellence with its customers, which primarily include market-leading international groups. PCAS designs and delivers the best industrial solutions for its customers' specific expectations. These various expectations all share a common demand for safety, quality, competitiveness, innovation and sustainability. PCAS also develops ranges of proprietary products based on intellectual property.

________________________________________________________________________________________________________________________________